Anders Folkesson

Anders Folkesson

Auto-generated profile, based on publicly available information

Anders Folkesson

National Veterinary Institute, Technical University of Denmark, Frederiksberg, Denmark

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2012 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
AFAnders Folkesson
Anders Folkesson
LJLars Jelsbak
Lars Jelsbak
LYLei Yang
Lei Yang
HJHelle Krogh Johansen
Helle Krogh Johansen
OCOana Ciofu
Oana Ciofu
SMSoren Molin
Soren Molin

25 April 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LYLei Yang
Lei Yang
LJLars Jelsbak
Lars Jelsbak
RMRasmus Marvig
Rasmus Marvig
SDSøren Damkiær
Søren Damkiær
CWChristopher T. Workman
Christopher T. Workman
SMSoren Molin
Soren Molin
Laboratory evolution experiments have led to important findings relating organism adaptation and genomic evolution. However, continuous monitoring of long-term evolution has been lacking for natural systems, limiting our understanding of these processes in situ. Here we characterize the evolutionary dynamics of a lineage of a clinically important opportunistic bacterial pathogen,Pseudomonas aeruginosa, as it adapts to the airways of several individual cystic fibrosis patients over 200,000 bacterial generations, and provide estimates of mutation rates of bacteria in a natural environment. In contrast to predictions based on in vitro evolution experiments, we document limited diversification of the evolving lineage despite a highly structured and complex host environment. Notably, the lineage went through an initial period of rapid adaptation caused by a small number of mutations with pleiotropic effects, followed by a period of genetic drift with limited phenotypic change and a genomic signature of negative selection, suggesting that the evolving lineage has reached a major adaptive peak in the fitness landscape. This contrasts with previous findings of continued positive selection from long-term in vitro evolution experiments. The evolved phenotype of the infecting bacteria further suggests that the opportunistic pathogen has transitioned to become a primary pathogen for cystic fibrosis patients.

30 June 2011 in The ISME Journal
Verified
Journal Article
Closed access
SHSusse Kirkelund Hansen
Susse Kirkelund Hansen
MRMartin Holm Rau
Martin Holm Rau
HJHelle Krogh Johansen
Helle Krogh Johansen
OCOana Ciofu
Oana Ciofu
LJLars Jelsbak
Lars Jelsbak
SMSoren Molin
Soren Molin
The opportunistic pathogen Pseudomonas aeruginosa is a frequent colonizer of the airways of patients suffering from cystic fibrosis (CF). Depending on early treatment regimens, the colonization will, with high probability, develop into chronic infections sooner or later, and it is important to establish under which conditions the switch to chronic infection takes place. In association with a recently established sinus surgery treatment program for CF patients at the Copenhagen CF Center, colonization of the paranasal sinuses with P. aeruginosa has been investigated, paralleled by sampling of sputum from the same patients. On the basis of genotyping and phenotypic characterization including transcription profiling, the diversity of the P. aeruginosa populations in the sinuses and the lower airways was investigated and compared. The observations made from several children show that the paranasal sinuses constitute an important niche for the colonizing bacteria in many patients. The paranasal sinuses often harbor distinct bacterial subpopulations, and in the early colonization phases there seems to be a migration from the sinuses to the lower airways, suggesting that independent adaptation and evolution take place in the sinuses. Importantly, before the onset of chronic lung infection, lineages with mutations conferring a large fitness benefit in CF airways such as mucA and lasR as well as small colony variants and antibiotic-resistant clones are part of the sinus populations. Thus, the paranasal sinuses potentially constitute a protected niche of adapted clones of P. aeruginosa, which can intermittently seed the lungs and pave the way for subsequent chronic lung infections.

3 October 2016 in Nature Communications
Verified
Journal Article
Open access
NJNicholas Jochumsen
Nicholas Jochumsen
RMRasmus Marvig
Rasmus Marvig
SDSøren Damkiær
Søren Damkiær
RJRune Lyngklip Jensen
Rune Lyngklip Jensen
WPWilhelm Paulander
Wilhelm Paulander
AFAnders Folkesson
Anders Folkesson
Colistin is an antimicrobial peptide that has become the only remaining alternative for the treatment of multidrug-resistant Gram-negative bacterial infections, but little is known of how clinical levels of colistin resistance evolve. We use in vitro experimental evolution and whole-genome sequencing of colistin-resistant Pseudomonas aeruginosa isolates from cystic fibrosis patients to reconstruct the molecular evolutionary pathways open for high-level colistin resistance. We show that the evolution of resistance is a complex, multistep process that requires mutation in at least five independent loci that synergistically create the phenotype. Strong intergenic epistasis limits the number of possible evolutionary pathways to resistance. Mutations in transcriptional regulators are essential for resistance evolution and function as nodes that potentiate further evolution towards higher resistance by functionalizing and increasing the effect of the other mutations. These results add to our understanding of clinical antimicrobial peptide resistance and the prediction of resistance evolution.

1 January 2007 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
JHJanus A. J. Haagensen
Janus A. J. Haagensen
MKMikkel Klausen
Mikkel Klausen
RERobert Ernst
Robert Ernst
SMSamuel I. Miller
Samuel I. Miller
AFAnders Folkesson
Anders Folkesson
SMSoren Molin
Soren Molin
DuringPseudomonas aeruginosaflow cell biofilm development, the cell population differentiates into a nonmotile subpopulation which forms microcolonies and a migrating subpopulation which eventually colonizes the top of the microcolonies, resulting in the development of mushroom-shaped multicellular structures. The cap-forming subpopulation was found to develop tolerance to membrane-targeting antimicrobial agents, such as the cyclic cationic peptide colistin and the detergent sodium dodecyl sulfate. The stalk-forming subpopulation, on the other hand, was sensitive to the membrane-targeting antibacterial agents. All biofilm-associated cells were sensitive to the antibacterial agents when tested in standard plate assays. A mutation eliminating the production of type IV pili, and hence surface-associated motility, prevented the formation of regular mushroom-shaped structures in the flow cell biofilms, and the development of tolerance to the antimicrobial agents was found to be affected as well. Mutations in genes interfering with lipopolysaccharide modification (pmr) eliminated the biofilm-associated colistin tolerance phenotype. Experiments with a PAO1 strain harboring apmr-gfpfusion showed that only the cap-forming subpopulation in biofilms treated with colistin expresses thepmroperon. These results suggest that increased antibiotic tolerance in biofilms may be a consequence of differentiation into distinct subpopulations with different phenotypic properties.

1 January 2002 in Research in Microbiology
Verified
Journal Article
Closed access
AFAnders Folkesson
Anders Folkesson
SLSven Löfdahl
Sven Löfdahl
SNStaffan Normark
Staffan Normark